|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes |
IUPAC Name ![]() |
| 2-[4-[(3Z)-3-[2-(Trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 1745 | flupentixol |
Synonyms ![]() |
| cis flupenthixol |
| alpha-flupenthixol |
| flupenthixol |
Database Links ![]() |
|
| CAS Registry No. | 53772-82-0 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL54661 |
| DrugBank Ligand | DB00875 |
| PubChem CID | 5281881 |
| Search Google for chemical match using the InChIKey | NJMYODHXAKYRHW-DVZOWYKESA-N |
| Search Google for chemicals with the same backbone | NJMYODHXAKYRHW |
| Search PubMed clinical trials | flupentixol |
| Search PubMed titles | flupentixol |
| Search PubMed titles/abstracts | flupentixol |
| Wikipedia | Flupentixol |
| Comments |
| The approved drug flupentixol (aka flupenthixol) is the cis form. Flupenthixol is not approved for marketing by US FDA, but is available in other countries. For the structure of the trans form please see our entry for trans-flupenthixol. |